Article
CAR-T design: Elements and their synergistic function
30 Jul 2020
Abstract excerpt
Chimeric antigen receptor (CAR) T cells use re-engineered cell surface receptors to specifically bind to and lyse oncogenic cells. Two clinically approved CAR-T-cell therapies have significant clinical efficacy in treating CD19-positive B cell cancers. With widespread interest to deploy this immunotherapy to other cancers, there has been great research activity to design new CAR structures to increase the range...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
